News&Blogs
The global medical tubing market is undergoing a structural expansion that no medical device manufacturer can afford to ignore. According to MarketsandMarkets, the market was valued at USD 12.53 billion in 2025 and is projected to reach USD 18.41 billion by 2030, growing at a compound annual growth rate (CAGR) of 8.0%. For extrusion equipment buyers and medical device OEMs, this translates into one clear imperative: your precision extrusion capabilities must scale with demand — now.
Minimally invasive surgery (MIS) is no longer a niche. From cardiovascular interventions to neurovascular procedures, catheters and cannulas have become the backbone of modern surgical practice. Each MIS procedure — whether a balloon angioplasty or a transcatheter aortic valve replacement — requires multiple single-use, precision-extruded medical tubes with sub-millimeter tolerances. As MIS adoption accelerates across Asia-Pacific, Latin America, and Africa, the demand pipeline for medical-grade extrusion equipment is stretching well beyond traditional markets.
The data confirms this: catheter and cannula applications alone account for the fastest-growing segment within medical tubing, driven by an aging global population and rising chronic disease prevalence. A manufacturer investing in a high-precision extrusion line today is positioning for a decade-long demand tailwind.
The post-pandemic shift toward home-based care has permanently altered the medical consumables landscape. Patients managing chronic conditions — diabetes, kidney failure, respiratory diseases — increasingly rely on at-home devices: insulin pumps, oxygen concentrators, peritoneal dialysis systems. Each of these devices depends on disposable medical tubing — IV lines, catheters, and fluid transfer tubes — that must be produced in high volumes with unwavering quality.
This surge in disposable tubing demand is reshaping procurement strategies. Medical device OEMs are seeking equipment partners who can deliver multi-lumen, co-extruded, and color-coded tubing with consistent batch-to-batch repeatability. The era of single-spec, single-material extrusion is giving way to a more complex production environment where one machine must produce multiple tube configurations — single-pipe, striped, co-extruded, and twin-pipe variants — all from one extrusion line.
Material science is the quiet engine behind medical tubing growth. Traditional PVC and silicone remain workhorse materials, but the market is increasingly demanding thermoplastic elastomers (TPE), polyurethane (PU), and multi-layer co-extrusions that combine strength, flexibility, and chemical resistance in a single tube profile. MarketsandMarkets identifies co-extruded tubing as the largest structural segment, precisely because it enables OEMs to layer materials with different properties — a stiff outer layer for pushability, a lubricious inner layer for guidewire passage.
This material complexity places new demands on extrusion equipment. A modern medical tube extrusion line must handle PVC, PP, PE, and PU across a range of melt temperatures and viscosities without compromising dimensional accuracy. Chenxing Machinery's PU/PE/PVC precision medical tube extrusion line is engineered for exactly this multi-material reality, with frequency-controlled extrusion speed, automatic temperature regulation, and ball-head connecting rod structure ensuring dual-tube output at consistent quality.
| Region | Key Driver | Opportunity |
|---|
| North America | FDA QMSR implementation (Feb 2026), aging population | IQ/OQ/PQ-validated equipment demand |
| Europe | MDR compliance, sustainability mandates | Energy-efficient, traceable extrusion lines |
| Asia-Pacific | Healthcare infrastructure expansion, medical tourism | Cost-competitive high-volume production |
| Middle East & Africa | New hospital construction, device localization | Turnkey extrusion line solutions |
For medical device manufacturers evaluating new production line investments, regional regulatory dynamics now weigh as heavily as unit economics. The FDA's Quality Management System Regulation (QMSR), effective February 2, 2026, incorporates ISO 13485:2016 by reference — meaning extrusion equipment must support rigorous process validation (IQ/OQ/PQ) documentation from day one.
If you are producing or planning to produce medical tubing — whether infusion tubes, catheter tubes, oxygen tubes, or specialized chemical transfer lines — your equipment choices today will define your competitive position through 2030. Here are the non-negotiable capabilities your next extrusion line must deliver:
Multi-material compatibility: PVC, PP, PE, PU — processed on the same line with minimal changeover time.
Precision speed control: Frequency-controlled extruder and haul-off systems for sub-millimeter tolerance.
Integrated quality marking: Oil-ink printing before cooling for permanent, legible tube identification.
Automated process control: Automatic water level and temperature regulation in the cooling tank; automatic winding with displacement adjustment.
Validation-ready documentation: Equipment designed to support IQ/OQ/PQ qualification per FDA QMSR and ISO 13485 requirements.
At Zhangjiagang Chenxing Machinery Co., Ltd., we have spent over 20 years building extrusion and compounding systems for global manufacturers. Our PU/PE/PVC Precision Medical Tube Extrusion Line is designed from the ground up for the realities of 2026-and-beyond medical device manufacturing: ISO 9001 and CE certified, export-ready to 30+ countries, and supported by a global after-sales network spanning Asia, the Middle East, and beyond.
The primary drivers are the global adoption of minimally invasive surgical procedures, the expansion of home healthcare (which increases disposable tubing consumption), and the shift toward advanced biocompatible materials such as TPE and multi-layer co-extruded structures. Regulatory modernization — particularly the FDA's QMSR and Europe's MDR — is also pushing manufacturers toward higher-precision, better-documented extrusion equipment.
The PU/PE/PVC Precision Medical Tube Extrusion Line can manufacture single tubes, striped single tubes, co-extruded tubes, multi-layer tubes, and tubes with color markings. It supports PVC, PP, PE, and PU materials and is suitable for infusion tubes, catheter tubes, oxygen tubes, and chemical fluid transfer applications.
The line is built with frequency-controlled speed regulation, automatic temperature and water-level control, and precision traction systems — all of which generate consistent, documentable process parameters required for IQ, OQ, and PQ validation under FDA QMSR (21 CFR Part 820) and ISO 13485:2016 frameworks. For detailed compliance documentation, contact our engineering team.
Yes. The line supports single-pipe, dual-pipe (same or different caliber), and co-extruded configurations. Its ball-head connecting rod structure and guide-post positioning enable simultaneous dual-tube extrusion without cross-interference, making it ideal for manufacturers who need production flexibility.
We provide comprehensive after-sales support including remote commissioning guidance, online operator training, spare parts supply, and overseas engineer dispatch when required. With offices in Guangdong, Thailand, Vietnam, and Malaysia, we ensure rapid regional response for our global customer base.
The medical tubing market is not just growing — it is transforming. The $18.41 billion opportunity by 2030 will belong to manufacturers who act now to secure precision extrusion capacity, regulatory-ready documentation, and multi-material production flexibility. Contact Chenxing Machinery today for a personalized consultation on your medical tube extrusion line requirements. Let us help you turn market growth into your growth.
